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ABSTRACT
Introduction: Postoperative delirium, arbitrarily defined
as occurring within 5 days of surgery, affects up to 50%
of patients older than 60 after a major operation. This
geriatric syndrome is associated with longer intensive
care unit and hospital stay, readmission, persistent
cognitive deterioration and mortality. No effective
preventive methods have been identified, but preliminary
evidence suggests that EEG monitoring during general
anaesthesia, by facilitating reduced anaesthetic exposure
and EEG suppression, might decrease incident
postoperative delirium. This study hypothesises that EEG-
guidance of anaesthetic administration prevents
postoperative delirium and downstream sequelae,
including falls and decreased quality of life.
Methods and analysis: This is a 1232 patient, block-
randomised, double-blinded, comparative effectiveness
trial. Patients older than 60, undergoing volatile agent-
based general anaesthesia for major surgery, are eligible.
Patients are randomised to 1 of 2 anaesthetic
approaches. One group receives general anaesthesia with
clinicians blinded to EEG monitoring. The other group
receives EEG-guidance of anaesthetic agent
administration. The outcomes of postoperative delirium
(≤5 days), falls at 1 and 12 months and health-related
quality of life at 1 and 12 months will be compared
between groups. Postoperative delirium is assessed with
the confusion assessment method, falls with ProFaNE
consensus questions and quality of life with the
Veteran’s RAND 12-item Health Survey. The intention-
to-treat principle will be followed for all analyses.
Differences between groups will be presented with 95%
CIs and will be considered statistically significant at a
two-sided p<0.05.
Ethics and dissemination: Electroencephalography
Guidance of Anesthesia to Alleviate Geriatric Syndromes
(ENGAGES) is approved by the ethics board at
Washington University. Recruitment began in January
2015. Dissemination plans include presentations at
scientific conferences, scientific publications, internet-
based educational materials and mass media.
Trial registration number: NCT02241655; Pre-results.
BACKGROUND
Within the next 40 years, >110 million
Americans will exceed the age of 60,1 and
many of them (>40%) will require elective
surgery.2 The geriatric syndrome of post-
operative delirium is one of the most
common complications observed with the
physiological stress of major surgery and
anaesthesia. It affects up to 70% of surgical
patients older than 60, with most studies
showing an incidence of 30–50%.3 Delirium
is an acute and fluctuating neurologic dis-
order that reflects a change from baseline
cognition and is characterised by the cardinal
features of inattention and disorganised
thinking.4 Postoperative delirium typically
first manifests between 24 and 96 hours fol-
lowing the surgical intervention. While it is
unclear why postoperative delirium occurs so
Strengths and limitations of this study
▪ The Electroencephalography Guidance of
Anesthesia to Alleviate Geriatric Syndromes
(ENGAGES) study is a pragmatic clinical trial,
conducted in a real world clinical setting.
▪ The electroencephalography-guided anaesthetic
protocol is straightforward and inexpensive; it
would be feasible to disseminate and implement
broadly.
▪ The effectiveness of the electroencephalography-
guided anaesthetic protocol will depend on clini-
cians’ adherence to the protocol.
▪ As delirium is a fluctuating disorder, it may occa-
sionally be missed despite rigorous and validated
assessment methods.
▪ Some patients might be unable to speak in the
early postoperative period (eg, have a tracheal
tube in place), which will curtail the sensitivity of
delirium assessment.
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frequently, consistently described risk factors for delirium
include older age, male sex, mild cognitive impairment,
dementia, sensory impairment and chronic medical
illness.5
Postoperative delirium has substantial implications at a
societal level for healthcare professionals and for individ-
ual patients and their families. It is estimated that delir-
ium is associated with additional healthcare costs
exceeding US$60 000 per patient per year.6 The occur-
rence and the duration of delirium are linked with
increased morbidity and mortality, prolonged length of
hospital and intensive care unit (ICU) stay, as well as
functional and cognitive decline necessitating nursing
home or long-term care facility placement.7–10
Preoperative surveys completed by 1000 patients at our
institution, Barnes-Jewish Hospital, a tertiary care facility
at Washington University in St. Louis, showed that ∼40%
of surgical patients highlight postoperative delirium (or
acute confusion) as one of their top concerns, and 30%
of all patients are worried that they will still have pro-
blems thinking normally when they return home to
recover. Another survey study showed that when
in-hospital delirium occurs patients’ family members are
deeply affected by the acute neurologic deterioration
and the impact upon recovery.11
Delirious patients are unable to participate effectively
in rehabilitation and are therefore susceptible to other
postoperative geriatric syndromes and adverse events,
including falls, pressure ulcers, functional decline, pneu-
monia, hospital readmission and discharge to a nursing
home or extended care facility.8 12–16 There is even evi-
dence that patients who have periods of delirium while
in hospital may continue to experience persistent delir-
ium after going home, and among these patients, the
risks of mortality, institutionalisation and functional and
cognitive decline are even worse than those patients
who experienced delirium but recovered.17 Patients who
experience postoperative delirium report persistently
decreased quality of life.8 Furthermore, additional
studies suggest that incidence and duration of delirium
may be associated with long-term postoperative cognitive
dysfunction.18 19 It is therefore a public health priority
to test plausible interventions to prevent, identify and
treat postoperative delirium.
Even though postoperative delirium is a pressing
healthcare concern, there are barriers to making pro-
gress in its prevention and treatment. Delirium is diffi-
cult to diagnose as most patients with delirium are
hypoactive or lethargic20 while medical staff typically rec-
ognise delirium when patients are hyperactive and agi-
tated. Hypoactive characteristics may also be easily
regarded as a normal phenotype in a patient recovering
from surgery or general anaesthesia. Furthermore, no
group of healthcare practitioners involved in the direct
surgical care of patients has taken ownership of delirium
as a priority needing their attention. It is not currently
standard of care to routinely assess surgical patients for
delirium, approaches for preventing postoperative
delirium have not been applied to surgical patients and
treatment options for delirium are limited. Delirium is a
common complication of surgery and anaesthesia with
serious consequences for patients and their families, yet
it remains an orphan problem, and no effective prophy-
lactic or curative treatments for postoperative delirium
have been identified.
Detecting delirium routinely in surgical patients using a
validated and practical approach like the confusion assess-
ment method (CAM)21 could allow target therapies and
potentially improve outcomes. For example, the Hospital
Elder Life Program (HELP)22 23 has been demonstrated
to be effective for prevention of postoperative delirium,
and principles and protocols from this programme will
be used in the proposed study. In addition, although the
effectiveness of the Acute Care for Elders model has not
yet been evaluated in the postoperative setting, delirious
patients could be targeted to receive components of this
model (frequent medical review, early rehabilitation,
early discharge planning, prepared environment, patient-
centred care), all of which have been shown to decrease
geriatric syndromes, such as falls, in vulnerable
patients.24 25 Identifying and if possible preventing delir-
ium in surgical patients might present an important
opportunity to improve numerous outcomes beyond a
reduction in the delirium burden.
Although it is very likely that anaesthetic management
contributes to the occurrence of postoperative delirium,
to date there are no validated anaesthetic approaches to
preventing delirium. Four randomised, controlled
studies in diverse surgical settings have suggested a
decrease in postoperative delirium with bispectral index
(BIS) guidance of general anaesthesia.26–29 The BIS is
one of several proprietary EEG indices of anaesthetic
depth, on the basis of EEG waveform processing, with
numbers approaching 100 suggesting arousal or wakeful-
ness, and numbers approaching 0 reflecting absent
detectable brain electrical activity.30 A meta-analysis of
these four randomised controlled trials showed that
EEG (or BIS) guidance of anaesthesia was associated
with a marked reduction in postoperative delirium with
a pooled OR of 0.56 (95% CI 0.42 to 0.73, heterogeneity
p value=0.54).29 Also of interest are several studies that
have examined the relationship between low intraopera-
tive BIS values and intermediate term postoperative mor-
tality.31–35 Building on these a study has demonstrated
that intraoperative EEG burst suppression specifically,
especially when coinciding with hypotension, is asso-
ciated with increased 90-day postoperative mortality.36
Despite the findings from these studies and recommen-
dations from the National Institute for Health and Care
Excellence in the UK that electroencephalography guid-
ance of anaesthesia should be routine for vulnerable
patients,37 intraoperative EEG monitoring has not
become standard anaesthetic practice, and there is
ongoing controversy about the utility of electroencephal-
ography guidance of anaesthesia.38 For example, in the
UK only 2% of anaesthesia practitioners routinely
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incorporate EEG monitoring in their practice,39 and it is
possible that adoption is similarly low in the USA. The
results of several clinical trials have led anaesthesia practi-
tioners to question whether EEG-guidance meaningfully
changes anaesthetic administration in real world set-
tings,40–42 and the mechanisms by which EEG-guidance
could decrease postoperative delirium have not been
clarified. In the USA, the American Society of
Anesthesiologists in its most recent guidelines on brain
monitoring does not recommend EEG monitoring as
standard care for any patient population, procedure or
anaesthetic technique.43 A pragmatic, randomised clin-
ical trial would address this controversy and could help to
inform the standard of care going forward. The plausibil-
ity for EEG guidance preventing postoperative delirium is
that it might help practitioners to avoid excessive anaes-
thetic administration to vulnerable patients.44 During
general anaesthesia, BIS values <30 are usually reflective
of periods of EEG burst suppression,45 46 which is often
indicative of excessively deep anaesthesia (see figure 1).
One study found a specific association between low BIS
values and postoperative delirium, and the investigators
hypothesised that burst suppression could be linked to
postoperative delirium.28 An observational study in
cardiac surgery patients reported an association between
intraoperative burst suppression and postoperative delir-
ium,47 and similarly EEG suppression in critically ill
patients reportedly predicts postcoma delirium.48 EEG
burst suppression and low BIS values have sometimes
been shown to be associated with intermediate term mor-
tality after surgery and critical illness.31–36 49 50 The pro-
posed Electroencephalography Guidance of Anesthesia
to Alleviate Geriatric Syndromes (ENGAGES) study is
designed as a parallel group, pragmatic, superiority trial
to test whether a simple EEG-guided protocol, designed
to minimise epochs of low BIS values and EEG burst sup-
pression, prevents postoperative delirium as well as its
downstream public health sequelae, such as deterioration
in health-related quality of life and injurious falls. The
ENGAGES study has three main hypotheses: (1)
EEG-guidance of anaesthesia is effective in preventing
delirium; (2) through prevention of delirium,
EEG-guided anaesthesia prevents postoperative falls and
improves patient-reported quality of life and (3) provid-
ing a targeted safety intervention will prevent post-
operative falls.
METHODS
Research design overview
The Human Research Protection Office at Washington
University School of Medicine has approved the study.
This protocol, which details the design of the ENGAGES
study, includes all the elements elaborated in the SPIRIT
(Standard Protocol Items: Recommendations for
Interventional Trials) checklist.51 52 The ENGAGES
study will be a pragmatic randomised clinical trial enrol-
ling 1232 patients 60 years and older who will undergo
elective major surgery at Barnes Jewish Hospital,
St. Louis, Missouri, USA. This hospital is an academic
medical centre in the Midwestern USA, which is
affiliated to Washington University School of Medicine
and serves a diverse range of patients in St. Louis and its
environs. Eligible patients will often be recruited
through the Center for Preoperative Assessment
and Planning (CPAP) clinic at Barnes Jewish Hospital.
Surgical patients might also be enrolled on hospital
wards prior to their surgery. Participants
will be randomly assigned to receive the electro-
encephalography-guided protocol or routine care.
Assessments will be conducted at baseline, in the post-
operative period during the hospital stay, at 30 days and
at 1-year postsurgery. The primary outcome measure will
be the incidence of postoperative delirium. During the
1-year follow-up period, health-related quality of life
information and information on incident falls will be
collected. At Washington University, surgical patients
have been enrolled in the Systematic Assessment
and Targeted Improvement of Services Following
Yearly Surgical Outcomes Surveys (SATISFY-SOS—
NCT02032030) study since 2012. For the exploratory
aim 3, there will be a prospective comorbidity-matched
cohort study using the ENGAGES clinical trial popula-
tion and reference subjects from the ongoing
SATISFY-SOS study (see figure 2). There is ongoing
rolling enrolment of participants to the SATISFY-SOS
study, and information on patients is continuously being
collected, updated and stored in a SQL Server database
(Microsoft, Redmond, Washington, USA) hosted by the
Institute of Quality Improvement, Research and
Informatics at Washington University.
Study subjects
This study proposes to enrol 1232 patients who are
already enrolled in the SATISFY-SOS study. Patients
60 years old and older, who are competent to provide
Figure 1 Stylized common EEG patterns from frontal EEG
channel seen with progressively increasing anaesthetic depth.
BIS, bispectral index.
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informed consent and who are undergoing major elect-
ive surgery under general anaesthesia with a potent
volatile anaesthetic agent that requires a minimum stay
of 2 days postoperatively (eg, open cardiac surgery,
open thoracic surgery, major vascular surgery,
intra-abdominal surgery, open gynaecologic surgery,
open urologic surgery, major orthopaedic surgery, open
hepato-biliary surgery and major ear, nose and throat
surgery), will be eligible for inclusion. As there are no
absolute contraindications to EEG monitoring, the
ENGAGES study is designed as a practical trial that will
have minimal exclusions and therefore maximum
applicability. Neurosurgical procedures will be excluded
as surgery on the brain can confound the outcome
(postoperative delirium). We will also exclude patients
with preoperative delirium and patients who are unable
to participate adequately in delirium screening includ-
ing those who are blind, deaf or illiterate or not fluent
in English. Patients with a history of intraoperative
awareness during intended general anaesthesia will also
be excluded.53 Patients will be excluded if, prior to their
index surgery, a second surgery is planned to occur
within 5 days after the index surgery. Figure 3 outlines
the flow of participants in the ENGAGES study.
Recruitment
All patients will provide written informed consent for
the study. Patients will often be recruited through the
CPAP clinic at Barnes Jewish Hospital, St. Louis,
Missouri. The majority of adults undergoing surgery at
Barnes-Jewish Hospital, about 30 000 patients per year,
are evaluated at CPAP. This clinic is staffed by anaesthe-
siologists specialising in perioperative medicine and
nurses who aim to evaluate each surgical patient’s peri-
operative risks. On average, the time frame between
study enrolment at the CPAP clinic and elective surgery
will be 1 week. Surgical patients might also be enrolled
on hospital wards prior to their surgery.
After the research team has established the reliability
of the delirium assessments, 100 patients will be enrolled
to the pilot phase of the ENGAGES trial during the first
year. In years 2–4, an accrual rate of 300–400 patients
per year is anticipated. To maximise efficiency, data
from the pilot will be included in the main study.54 In
this pilot cohort, practical aspects of the trial’s conduct
will be evaluated. These include the feasibility of enrol-
ling adequate numbers of patients in the preoperative
assessment clinic; the ability of researchers to conduct
the baseline preoperative assessments; the demonstration
of retrieval of complete perioperative data (including
repeated measures of EEG-derived parameters) from the
electronic medical record; successful daily postoperative
delirium assessments until postoperative day 5 or hospital
discharge (for patients who remain delirious at day 5
they will be assessed until they return to baseline or until
postoperative day 10); and near complete (>80%) 30-day
patient-reported outcomes data.
On the basis of data from previous large clinical trials
completed at our site, we expect the study population to
be largely balanced between sexes and representative of
Figure 2 Flow diagram showing design overview for ENGAGES study.
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our environs. In two of our previous studies, we enrolled
6700 patients in St. Louis, Missouri. Results showed
slightly higher enrolment of males versus females (55%
vs 45%), and racial demographics of ∼80% white and
20% black or other.40 41 These results are generally rep-
resentative of the population in metropolitan St. Louis
and surrounding regions, where the majority of our
patients reside. On the basis of 2011 census data,
median household income and education levels of the
population of St. Louis metropolis are representative of
the national average. The ENGAGES study will enrol
patients older than 60. Older patients constitute a vul-
nerable population and have often been under-
represented in clinical research. We anticipate that the
patients enrolled in the ENGAGES study will be broadly
representative of the older adult population of the USA,
recognising that certain demographics (eg, Hispanic)
are under-represented in St. Louis. The follow-up period
after randomisation is ∼1 year.
Randomisation and blinding
Randomisation will be performed at the patient level
using computer-generated assignment. Eligible patients
who provided written informed consent will be
randomised to receive the intraoperative electro-
encephalography-guided protocol or routine care. To
ensure that there is not major imbalance between
group assignments with respect to history of falls and
cardiac surgery, patients will be randomised (1:1)
between the EEG-guided and routine care groups in
blocks of 20 within these four strata (ie, cardiac
surgery with a history of falls within 6 months, cardiac
surgery without a history of falls within 6 months, non-
cardiac surgery with a history of falls within 6 months
and non-cardiac surgery without a history of falls within
6 months). Trained members of the research team will
enrol participants and will implement the assignment of
participants to the EEG-guided or usual care protocols.
Group assignment will be revealed to members of the
anaesthetic team only when the patient enters the oper-
ating room by opening a sequentially numbered,
opaque, sealed envelope in a sequence generated by
one of the study’s data analysts. Patients and their fam-
ilies will be blinded to group allocation, and different
members of the research team will assist with the inter-
vention in the operating room (will not be blinded to
Figure 3 Flow of participants.
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the intervention) from those conducting the post-
operative assessments (will be blinded to the interven-
tion).51 52 To reduce predictability of a random
sequence, details of patients already randomised and
prior group assignments will be recorded in a separate
document that is unavailable to those who enrol partici-
pants and assign interventions.
Primary intervention—EEG-guided anaesthetic protocol
The primary intervention to which patients will be ran-
domised in this study is a pragmatic EEG-guided anaes-
thetic protocol (see online supplementary appendix).
All anaesthesia practitioners will receive a targeted edu-
cational session on recognition of EEG patterns typically
occurring during general anaesthesia. The content will
be similar to that described in an article where we
demonstrated that anaesthesiologists could estimate BIS
(processed EEG index) values fairly accurately based on
clinical context and examination of the raw EEG wave-
form.55 The BIS proprietary processed EEG monitor will
be used for the ENGAGES study. However, the anaesthe-
sia monitor in the operating room will be configured to
display, in addition to the processed EEG index, the raw
EEG waveform as well as non-proprietary EEG-derived
numerical values, including the burst suppression ratio
and the spectral edge frequency (figure 4). The hypoth-
esis motivating this study is that avoidance of EEG burst
suppression during anaesthesia can prevent post-
operative delirium (aim 1 in figure 2) and its down-
stream consequences (aim 2 in figure 2). Therefore,
practitioners will specifically be instructed to regularly
inspect the EEG waveform for evidence of burst suppres-
sion, which is easily recognised (see figure 1). The
occurrence of burst suppression is the chief trigger for
decreasing anaesthetic administration in this protocol.
An audible low-BIS alarm will be set at a threshold of 40,
as there is an increased likelihood of epochs of EEG
burst suppression below this value.45 BIS values <40 will
be a secondary trigger for decreasing anaesthetic admin-
istration. Importantly, the EEG-guided protocol is sug-
gestive rather than prescriptive. Clinicians should
exercise judgement and might intentionally deviate from
the protocol depending on the clinical situation. In both
groups, there will be an audible alarm for a low volatile
anaesthetic agent (at 0.3 minimum alveolar concentra-
tion or at the clinician’s discretion), which is a standard
practice at our institution to prevent intraoperative aware-
ness. BIS EEG sensors will also be applied to patients in
the control group for the purpose of data comparisons
between groups, but when a patient is assigned to the
control arm, practitioners will be blinded to all the EEG
and BIS parameters and will only see the signal quality
index (SQI) of the EEG montage (figure 5). EEG moni-
toring may continue to be acquired via continuous
recordings of EEG, eye movements and chin muscle activ-
ity for patients who are admitted to the ICU and step-
down wards or if the hospital room allows. Patients and
research assistants assessing the study outcome measures
(eg, delirium assessments) will be blinded to the allo-
cated intervention.
Ensure practitioner fidelity to the EEG-guided protocol
In order for any monitor to alter clinical practice, clini-
cians must be able to glean useful information from the
monitor and should be motivated to make decisions
based on that information. One of the limitations
regarding EEG guidance of anaesthesia is that teaching
on electroencephalography is currently limited in anaes-
thesiology residencies and in nurse anaesthesia training
programmes. Given this, it is unsurprising that
EEG-based monitors have not been incorporated into
routine anaesthetic practice. Our research group pub-
lished a study showing that with a focused training
session, anaesthesiologists could learn to appreciate
Figure 4 The anaesthesia
monitor is configured for the
EEG-guided arm such that the
raw EEG waveform as well as the
non-proprietary numerical values
are displayed by the monitor,
including the burst suppression
ratio (SR) and the spectral edge
frequency (SEF). The EEG filter
is turned off so the low frequency
slow delta waves (with a
frequency of about 0.5 Hz) are
clearly visible. Turning off the
filter allows EEG waves ≤2 Hz to
be seen. The filter is a bandpass
filter from 2 to 70 Hz with a notch
to eliminate 60 Hz alternating
current electrical noise. With the
filter off, the system has a
bandwidth of ∼0.25– 100 Hz.
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some of the key EEG changes that occur with general
anaesthesia.55 We demonstrated that clinicians could
learn relatively rapidly to integrate clinical context with
EEG waveform information and could even accurately
estimate BIS values—an index derived via computer-
based processing of the raw EEG signal.55 With initiation
of the ENGAGES study, we launched a training module
on a non-profit international educational website,
International Consortium for Electroencephalograph
Training of Anesthesia Practitioners (http://www.icetap.
org), titled ‘EEG Waveforms and Depth of Anesthesia’.56
Key to the success of the ENGAGES study will be educat-
ing anaesthesia practitioners at our institution about the
EEG waveform and how information from the EEG can
be useful in guiding anaesthetic practice. Regarding
EEG-derived parameters specifically, we capture elec-
tronically proprietary (eg, BIS values) and non-
proprietary (eg, burst suppression ratio) data.
Therefore, we shall be able to ascertain from the phase
1 pilot study of 100 patients whether or not the
EEG-guided protocol alters anaesthetic administration
(eg, measured concentrations of volatile anaesthetic
agents) or EEG parameters (eg, cumulative duration of
EEG burst suppression). Given that the hypothesis of
the ENGAGES study is that EEG guidance in the real
world can alter anaesthetic management, which in turn
prevents postoperative delirium, an essential proof of
concept step in the pilot phase is to demonstrate our
ability to alter anaesthetic practice in a range of practi-
tioners when they use the EEG-guided protocol.
Secondary intervention—multicomponent safety
intervention
On the basis of findings that multicomponent non-
pharmacological protocols can improve sleep, decrease
episodes of delirium and improve outcomes,20 57 58 the
ENGAGES study will implement a multicomponent
intervention including principles from the HELP59 60
for all patients enrolled in the study to attempt to
prevent postdischarge falls and decrements in
health-related quality of life.20 57 58 61 These outcomes
will be tracked in all patients in the ENGAGES study as
they will also be enrolled in the SATISFY-SOS study.
Likewise, these outcomes will be ascertained in a
matched cohort of controls from the SATISFY-SOS
cohort who will not be enrolled in the ENGAGES study.
This will allow comparison in these outcomes between
patients receiving the multicomponent safety interven-
tion and matched controls (aim 3 in figure 2).
The interventions, implemented mainly after hospital
discharge, will include the following, as indicated:
reduction of psychoactive drugs; advice on non-
pharmacological approaches to manage sleep, anxiety
and agitation; involvement of family members in care,
particularly for reorientation and prevention of self-
harm; encouragement of mobility and self-care; ensuring
that, if needed, patients have glasses, hearing aids and
dentures; home visits by occupational therapists; tar-
geted home safety modifications; keeping patients
involved in their care and communicating regularly with
patients and their families.20 During the pilot phase,
patients and their family members will be called and
questioned about their perception of the utility of the
educational resources and, if relevant, the home visit.
Preoperatively, at the time of providing informed
consent for the ENGAGES study (but prior to random-
isation for the primary intervention), all participants
and their families will receive general information on
delirium and falls derived from the HELP59 60 and from
the Agency for Healthcare and Research Quality-Rand
(AHRQ-Rand) hospital fall prevention programme.62
The research team will provide participants and their
families with information about making the home envir-
onment safer to decrease the risk of falls and related
injuries. An information sheet on improving safety in
the hospital after surgery will also be provided (see
online supplementary appendices: see CDC Fall Safety
Information Sheet and Partners HealthCare Falls TIPS:
Tips to Avoid Falls While in the Hospital).
Postoperatively, prior to hospital discharge, the research
staff will review participants’ current medications and
provide recommendations regarding any medications
Figure 5 The anaesthesia
monitor is configured for the
control arm such that all the EEG
and BIS parameters are hidden,
and only the signal quality index
(SQI) of the EEG montage is
visible.
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with the potential to increase the risk of falls.63–69 We
will provide participants’ physicians with information
about any identified medications associated with fall or
delirium risk (eg, strong centrally acting anticholiner-
gics, benzodiazepines) and recommendations.70 Many of
these targeted medications were highlighted in the
recent American Geriatric Society Beers Criteria guide-
lines as potentially inappropriate medications for older
persons.70
Since a history of falls in older adults is associated with
increased fall risk,71 the research staff may recommend
and provide (if acceptable to patients and if patients live
<45 miles from the hospital) home occupational therapy
visits that have the general aim of improving daily activity
performance/safety and prevention of falls. Since delir-
ium in older adults is associated with increased fall
risk,72–76 the research staff will recommend that patients’
families exercise increased vigilance when delirium fea-
tures are noted in the hospital or after hospital dis-
charge. Patients and their families will also be reminded
about the home safety assessment tool that they received
at the time of enrolment (see online supplementary
appendix: CDC fall safety information sheet).
DATA COLLECTION
Baseline assessment will take place at the CPAP clinic
and include demographic information, a detailed
medical history, physical examination, assessment of pre-
operative quality of life and evaluation of falls history.
Delirium will be assessed daily in the postoperative
period of the hospital stay. Data collected specifically for
the ENGAGES study, such as the daily delirium assess-
ments, will be entered into the Washington University
School of Medicine Research Electronic Data Capture
(REDCap) application.77 In the ENGAGES study, EEG
data (including BIS values and EEG burst suppression
durations) will be collected in the intervention group as
well as in the blinded control group.36 50 Furthermore,
perioperative data (including repeated measures data)
will be retrieved from the hospital’s perioperative elec-
tronic medical record (Metavision by iMDsoft,
Needham, Massachusetts, USA).36 41 53 78 We are able
routinely to capture high fidelity perioperative data from
our MetaVision records to an SQL server (Microsoft,
Redmond, Washington, USA) database. Routinely
acquired data include detailed patient medical history,
surgical history, specific patient risk factors, medications,
Barthel Index, VR-12 quality of life data, Short Blessed
Test, sleep apnoea screening, laboratory data, intraopera-
tive medications, physiological readings and post-
operative recovery parameters. Olfaction might be
assessed preoperatively with the brief smell identification
test, as hyposmia has been identified as a risk factor for
postoperative delirium.79 All the data for SATISFY-SOS
are integrated from various data sources and are stored
in a single data repository housed in the Department of
Anesthesiology at Washington University.
Cognitive testing
When patients are assessed for delirium, structured cog-
nitive appraisal is performed, which gives the inter-
viewer an opportunity to make observations that are
used when scoring the CAM. In addition, as part of the
routine preoperative assessment, patients will be
screened for cognitive impairment with the AD-8
dementia screen80 and with the Short Blessed Test.81
Tests from the cognitive battery of the NIH toolbox
might also be incorporated in the baseline assess-
ment.82 83 This computer-based battery assesses
Executive Function, Attention, Episodic Memory,
Language, Processing Speed and Working Memory (see
online supplementary appendix). Depending on time
constraints, patients might complete a long form of the
cognitive battery or a version focused on executive func-
tion, episodic memory and attention. Patients who
prefer not to do computer-based cognitive tests will be
offered paper-based cognitive tests (Trails A and B, and
Stroop Color and Word Test). Impaired performance on
preoperative cognitive tests is reportedly associated with
postoperative delirium,84 85 and postoperative delirium
has been found to be associated with persistent post-
operative cognitive decline.18 Therefore, when patients
are followed up postoperatively at 30 days, the Short
Blessed Test will be administered on the telephone.
When patients are followed up postoperatively at 1 year,
the Short Blessed Test will be administered on the tele-
phone and, if possible, follow-up cognitive assessment
with the NIH toolbox will be arranged. Permission from
the NIH has been obtained to use the NIH Toolbox for
the ENGAGES study.
Frailty assessment
Various components of frailty are assessed routinely
in the CPAP clinic and as part of the SATISFY-SOS
study. These include weight loss, Charlson Comorbidity
Index, individual co-morbidities, preoperative anaemia
(haematocrit <35%), functional status, 6 months
history of falls and the Barthel Index.86 In addition to
these measures, for the ENGAGES study we plan to
measure grip strength and the Timed Up and Go
(TUG) test.86 Grip strength will be assessed with three
measurements in the dominant hand using a Jamar
handheld dynamometer (Lafayette Instruments,
Lafayette, Indiana, USA).87 Maximal grip strength will
be selected for analysis.
Patients’ postoperative health and well-being
All patients enrolled in the ENGAGES study will already
have provided informed consent for the SATISFY-SOS
study. Using the SATISFY-SOS infrastructure, the
ENGAGES study will track postoperative patient-reported
outcomes at ∼1 month and at 1 year. Patient-reported
outcomes tracked include health-related quality of life
and postoperative falls.
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Outcome measures
Incidence of postoperative delirium
Incident delirium is the primary outcome of the
ENGAGES trial (aim 1 in figure 2). A preoperative base-
line assessment will be performed when patients are
enrolled to participate in the ENGAGES study.
Preoperative delirium is rare before elective surgery and
will exclude participation in the study. Postoperative
delirium assessments will be performed when patients
can be aroused sufficiently to be assessed for delirium
(Richmond Agitation-Sedation Scale (RASS) >−4).
Patients will be assessed for delirium once daily in the
afternoon/evening. Each patient will be assessed for
delirium up to postoperative day 5. Delirium will be
diagnosed based on a combined approach consisting of
standardised daily CAM evaluations coupled with a struc-
tured chart review. The CAM has been described as a
viable tool to be used by non-psychiatrists for delirium
detection.21 It has subsequently been validated in
numerous studies and has a sensitivity of >94% and a
specificity of >89% against a reference standard.88
Trained research team members who are blinded to
treatment allocation will assess patients for incident
delirium (primary outcome) using the CAM.21 Patients
who are unable to speak (eg, have a tracheal tube or
tracheostomy) will instead be assessed using the confu-
sion assessment method for the intensive care unit
(CAM-ICU) instrument.89 90 These methods (the CAM
and the CAM-ICU) have been shown to be reliable and
to have good agreement with the DSM-IV criteria for
delirium.90–92 In addition to the CAM or the CAM-ICU,
an independent trained clinical researcher, blinded to
the CAM results, will conduct structured chart reviews to
detect episodes of delirium. A combined approach
(CAM interview or CAM-ICU plus chart review)
increases the sensitivity and retains specificity in detect-
ing incident delirium.93 94 Therefore, either a positive
clinical delirium assessment (CAM or CAM-ICU) or a
positive assessment for delirium based on a validated,
structured chart review93 94 will be diagnostic of incident
delirium in the ENGAGES trial. The use of the struc-
tured chart review will improve sensitivity and contribute
to the pragmatic aspects of this trial, since it will abstract
incident delirium from a routinely available source. The
trial staff will undergo training on the chart review meth-
odology by a skilled chart reviewer under the supervision
of Drs Inouye and Schmitt.
The CAM assessment that will be used in the
ENGAGES study was developed by Inouye et al.21 All
ENGAGES CAM assessments will be performed by study
team members who have undergone a rigorous training
process. Several members of the research team partici-
pated in a full-day CAM training programme led by Dr
Inouye, the original creator of the instrument.95 Those
who attended this initial training will oversee the train-
ing of other team members. All trainees must demon-
strate competence at conducting the structured
interviews and in correctly scoring subjects. Trainees
must first conduct at least two satisfactory CAM assess-
ments in patients not enrolled in the ENGAGES study in
the presence of a trained team member. To establish
competency in scoring the CAM, trainees will observe
CAM interviews conducted by trained team members
and will score the CAM independently. The trainee must
agree with the trainer on the presence or absence of all
12 cognitive features assessed by the CAM on a
minimum of two delirious and two non-delirious
patients. After meeting the stipulations of training, the
newly trained team member will conduct their first
interview of a patient enrolled into the ENGAGES trial
in the presence of a previously trained team member.
Independent of the training process, all ENGAGES
team members who are participating in CAM assess-
ments must view and rate nine videos of standard inter-
views of actors depicting delirious and non-delirious
patients. This process will help to demonstrate the
success of the training process and the extent to which
researchers reproducibly score the CAM. To establish
the reliability of delirium assessments in the clinical
setting, trained members of the research team will separ-
ately assess 30 patients not enrolled in the ENGAGES
study at similar time points (eg, within 2 hours of each
other). These assessments will determine the test–retest
reliability of delirium assessments by the research team.
This approach will provide >90% power to demonstrate
a κ statistic of >0.6, representing substantial or greater
agreement between raters.96
A structured process will be implemented to assess
and ensure the quality of the delirium assessments.
Every delirium assessment will be reviewed within 3 days
with a fellow member of the research team to assess
internal consistency of scoring and completeness. On a
weekly basis, investigators at Washington University will
review all the delirium assessments, will address meth-
odological inconsistencies and will attempt to resolve
controversies. Monthly, there will be a teleconference
including investigators from Hebrew SeniorLife/
Harvard University and from Washington University to
review challenging delirium assessments and to ensure
that the rigour of assessments remains appropriate.
During these conferences, the need for focused and
comprehensive refresher training in delirium assess-
ment95 will be determined.
If participants agree, these assessments may be video-
taped for training and education of the research team.
The videotapes will include the patients’ face.
Health-related quality of life
As part of the ongoing SATISFY-SOS study, patient self-
reported health-related quality of life information will be
assessed through the Veteran’s RAND 12-item Health
Survey at baseline (preoperatively) and during follow-up
(30-day and 1-year) (aims 2 and 3 in figure 2). The
VR-12 was derived from the Veterans RAND 36 Item
Health Survey (VR-36) and contains 12 items relating to
quality of life, including physical and mental health, as
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well as specific questions about functional status.
Physical and Mental Health Summary Scores will be cal-
culated. The VR-12 has been validated and is widely
applied as a metric for tracking health-related quality of
life in the USA.97
Falls
In the baseline (preoperative) questionnaire for the
SATISFY-SOS study, patients are asked to indicate how
many times they fell during the past 6 months and injur-
ies from falls are ascertained (aims 2 and 3 in figure 2).
Patients who fell at least one time during the past
6 months will be classified as having a previous history of
falls. On the 30-day and 1-year follow-up postoperative
questionnaires, patients are asked to indicate whether
they have experienced a fall. On the basis of this infor-
mation, we will define two outcome measures: falls
within 30-days and falls within 1-year of surgery. Data on
number of falls and injurious falls will also be collected.
The wording for the falls questions used in SATISFY-SOS
is based on the definition proposed by the Prevention of
Falls Network Europe (ProFaNE); the calculation for
severity of fall is based on a standard algorithm.98–100
Prespecified additional analyses and substudies
The primary aim of the ENGAGES study is to determine
whether an EEG-guided anaesthetic protocol can
decrease postoperative delirium and its associated down-
stream negative sequelae (eg, decrement in quality of
life, falls). However, it is important that large, rando-
mised trials collect and report data on multiple clinically
relevant outcomes to maximise scientific yield and effi-
ciency. The ENGAGES trial will have the potential to
contribute new information on diagnosis of post-
operative delirium, risk factors for postoperative delir-
ium and negative outcomes following incident
postoperative delirium. The ENGAGES trial will be con-
ducted using the infrastructure of the ongoing
SATISFY-SOS study, which is systematically collecting
detailed information on surgical patients’ characteristics,
and is tracking their health and well-being up to 5 years
postoperatively. The effect of anaesthetic depth on post-
operative morbidity and mortality is currently being
explored in the 6500 patient Balanced Anaesthesia
Trial.101 102 Information provided by the ENGAGES
study will add to the growing body of evidence regarding
the hypothesised effects of anaesthetic depth on surgical
outcomes. Prespecified substudies for the ENGAGES
trial are elaborated in an addendum at the end of this
protocol.
Patient-centered approach
Several aspects of the ENGAGES study are patient
centred in their conception. There is a community
liaison group that has been actively involved in the
design and in the conduct of the study. Important out-
comes in the study are based on patient-reported out-
comes measures. Both patients and their families are
provided with educational material on delirium, its risk
factors and its sequelae. The study also includes patient
self-assessment for delirium and implementation of the
validated FAM-CAM103 104 instrument in hospital and
after hospital discharge. These will be included in pre-
specified substudies of the ENGAGES trial (see
addendum).
Statistical analyses
Effectiveness of EEG-guided anaesthesia protocol in
reducing incident postoperative delirium compared with
usual anaesthetic care
We will follow the intention-to-treat principle for all ana-
lyses (aim 1 in figure 2). The primary end point of our
analysis is the incidence of postoperative delirium as
defined previously. The incidence of delirium will be
compared between groups using a χ2 test, and the differ-
ence in delirium incidence with 95% CIs will be calcu-
lated. Prespecified exploratory subgroup analyses: we will
test for effect modification by known baseline delirium
risk factors (ie, age (<70 and ≥70), sex, history of falls
and type of surgery (cardiac vs non-cardiac)).
Effectiveness of EEG-guided anaesthesia protocol in
improving patient-reported outcomes of health-related
quality of life and preventing postoperative falls
Health-related quality of life
Random effects regression models based on PROC
MIXED in SAS will be used to compare Physical
Summary Score change over 12 months between the
intervention and usual care group by introducing terms
for time, indicator variables for treatment group and
time×treatment group interactions with the latter set of
regression coefficients of primary interest (aim 2 in
figure 2). The model will be controlled for baseline
health-related quality of life. Potential confounding
factors including age, gender and relevant comorbidities
will be evaluated and controlled for in the model. We
will use the same analysis approach to evaluate the
Mental Summary Scores.
The analysis is primarily based on the following model:
Yit ¼ aþ b1t þ b2AXi1 þ b3AXi1t þ b4tYi0 þ eit ð1Þ
where Yit=QOL for subject i at time t, where t=0 for base-
line and t=1 for 12 months. Xi1=1 if ith subject is in the
intervention group, =0 otherwise. eit∼N(0, σ2) β3A is the
mean difference in Physical Summary Score change
between the intervention and usual care groups. The
coefficient β2A allows for mean differences in Physical
Summary Scores between groups at baseline. The coeffi-
cient β4 allows the change in Physical Summary Score to
depend on initial level.
Postoperative falls
A χ2 test will be used to compare the incidence of falls
at 12 months postoperatively between patients in the
EEG-guided and in the usual care groups.
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Explore whether a multicomponent safety intervention is
associated with improved patient-reported health-related
quality of life and decreased incidence of postoperative falls
We will design a prospective matched cohort study using
the ENGAGES participants (received multicomponent
safety intervention) and SATISFY-SOS patients who are
not enrolled in the ENGAGES study (did not receive
multicomponent safety intervention) (aim 3 in figure
2). Participants in the ENGAGES study will be matched
with reference individuals according to preoperative
characteristics. Reference individuals will be identified
through the ongoing SATISFY-SOS cohort and will be
matched by age (±1 year), American Society of
Anesthesiologists’ physical status (1–4), type of surgery
(cardiac vs non-cardiac), date of planned surgery
(±1 year) and history of falls (yes or no). Health-related
quality of life and fall incidence will be compared
between these matched cohorts at ∼1 month and 1 year
postoperatively.
All statistical analyses will be performed using SAS,
V.9.4 (SAS Institute, Cary, North Carolina, USA). All
tests will be two sided and by arbitrary convention105 will
be considered statistically significant at a p<0.05, and all
results will be presented with estimates and 95% CIs.
However, on the basis of the uncertain prior probability
(plausibility) of the alternative hypothesis106 (ie, EEG
guidance of anaesthesia decreases postoperative delir-
ium) and concerns raised about lack of reproducibility
in science,107 108 a statistically significant result with a
p value just <0.05 should be considered as preliminary,
and future studies should be conducted for corrobor-
ation. A more stringent p value (eg, p<0.005) would be
required to conclude that subsequent studies would be
very likely to reproduce these results with a p value
<0.05.109 Apart from statistical significance, the ultimate
decision regarding the routine implementation of EEG
guidance of general anaesthesia in preventing post-
operative delirium will also depend on the estimated
effect size of this intervention.
Sample size calculations
All sample size calculations have been performed using
SAS PROC POWER.
Decrease in delirium
Our sample size calculations are based on the antici-
pated delirium incidence and effect size for our primary
end point analysis. On the basis of results of a previously
published meta-analysis of four studies investigating the
use of BIS-guided anaesthetic administration, we conser-
vatively assume an incidence of postoperative delirium
in the routine anaesthesia care group of 25%.29 We per-
formed a sample size sensitivity analysis and calculated
different scenarios with different values for the delirium
incidence in the intervention arm and corresponding
power (80%, 90% and 95%). With a two-sided α <5%
and 1232 patients (616 per arm), the trial will have
>95% power to detect an absolute decrease in delirium
incidence ≥9%, >90% power to detect a decrease in
delirium incidence ≥8% and >80% power to detect a
decrease in delirium incidence ≥7%. With a 7%
decrease in delirium incidence, the 95% CI would be
∼3–12%. Even a 3% decrease in delirium incidence
would be clinically important, suggesting that delirium
would be prevented in one out of every 33 at risk
patients who received EEG guidance of general
anaesthesia.
Health-related quality of life
The overall sample size of our study is defined through
estimations of the primary outcome (delirium). For sec-
ondary analyses, we assume that ∼80% of our trial popu-
lation (∼1000 participants) will have completed the trial
and the 1-year follow-up survey. With this sample size of
1000, we can detect a difference of 0.5 points (SD of
2.5) in the mean change of Physical Health Score from
baseline to 1 year between the intervention and usual
care group with a power of >80% and a two-sided α level
of p<0.05.
Postoperative falls
This calculation is similarly based on the assumption
that ∼80% of our trial population (∼1000 participants)
will have completed the trial and the 1-year follow-up
survey. On the basis of a study that showed a preopera-
tive fall prevalence of 33% over 6 months preoperatively
in a similar patient population to the ENGAGES trial,
we will conservatively assume an incidence of post-
operative falls at 1-year in the routine anaesthesia care
group of 40%.110 With a sample size of 1000, we will
have >80% power to detect an absolute risk reduction of
12% between the EEG-guided and the usual care group
at a two-sided α level of p<0.05.
Analysis of pragmatic elements of the ENGAGES study
According to seven of nine criteria elaborated in the
pragmatic–explanatory continuum indicator summary
(PRECIS-2) tool,111 the ENGAGES trial is designed pre-
dominantly as a pragmatic rather than as an explanatory
study (see figure 6). (1) Regarding eligibility criteria, all
surgical patients older than 60 undergoing major surgi-
cal procedures are eligible for the ENGAGES study,
regardless of other known risk factors for delirium. As
such, this is broadly representative of a substantial popu-
lation of older surgical patients. However, the results
would not apply to younger patients or to older patients
undergoing non-invasive surgical procedures. (2)
Patients are recruited in usual clinical settings with
slightly more effort made over and above what would be
used in the usual care setting to engage with patients.
(3) The trial is being conducted in usual care settings,
predominantly in the operating rooms and in hospital
wards. (4) Any anaesthesia practitioner, regardless of
their background or expertise in EEG monitoring, can
apply the EEG-guided protocol. However, during the
first phase of the study, there will be structured
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education of clinicians to increase their familiarity and
comfort with EEG guidance of anaesthesia. We there-
fore anticipate that practitioner familiarity with EEG
will increase over the course of the study, although only
basic knowledge regarding EEG analysis will be needed.
Similarly, any anaesthesia practitioner, regardless of
their background or expertise, can apply the control
(comparison) protocol. (5) Instructions on how to
apply the EEG-guided protocol are flexible, offering
practitioners discretion in deciding how to formulate
and apply it. Although clinicians carrying out the
EEG-guided protocol will use their own discretion in
managing anaesthesia, there is an expectation that less
anaesthesia will be administered in the EEG-guided
arm and that the cumulative duration of EEG suppres-
sion will be less in the EEG-guided arm. During the
first phase of the study, clinician adherence to the
EEG-guided protocol will be evaluated and will partially
inform the value of proceeding with the second phase
of the study. Similar to the intervention arm, when
patients are randomised to the control arm, anaesthesia
clinicians will have leeway to pursue their usual practice
with minimal restrictions. There are some limitations in
relation to the anaesthetic technique (eg, based on
potent volatile anaesthetic); however, these are consist-
ent with current practice at our institution and more
broadly. (6) For the primary intervention of the
ENGAGES trial, participants will be anaesthetised and
will have no ability to impact adherence to the interven-
tion. Therefore, this domain was left blank in the
PRECIS-2 determination, as recommended.111 (7)
Patients enrolled to the ENGAGES trial will be followed
with more frequent visits and more extensive data col-
lection than would occur in routine practice. (8)
Incident delirium, the primary outcome of the study, is
an objectively measured, clinically meaningful outcome
to the study participants. The outcome can be assessed
under usual conditions and typically does not rely on
central adjudication. However, special training in rigor-
ous delirium assessment is required. It is important to
note that the abstraction of information about delirium
from the medical records bolsters the pragmatic aspects
of the trial, since this is an information source that is
readily available at any hospital. (9) The analysis of the
results will include all patients regardless of clinician
compliance with the EEG-guided protocol (ie, it will be
an ‘intention-to-treat’ analysis). The analysis will
attempt to determine whether or not the EEG-guided
protocol prevents postoperative delirium under the
usual conditions, with all the noise inherent therein.
Although in most respects the ENGAGES trial was
judged to be pragmatic, this appraisal might have been
biased as it was conducted by investigators associated
with the study.112
Figure 6 The design elements of the ENGAGES trial that tend to be pragmatic (markers placed towards the periphery) and
elements that tend to be explanatory (markers placed towards the centre).111 113 This figure was generated from a median
determination for each criterion (using a 1 to 5 ordinal scale from explanatory to pragmatic) from 18 independent raters on the
study team. Aside from the intensity of patient follow-up and the expertise needed to deliver the EEG-guided protocol, the
ENGAGES study fulfils the criteria for a pragmatic clinical trial.111 112
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Strengths and limitations
The ENGAGES study has important strengths. It is
largely a pragmatic randomised clinical trial conducted
in a high volume, real world clinical setting that incorpo-
rates an easy-to-implement intervention and examines
an outcome that is of tremendous importance to
patients, healthcare providers and society. The
ENGAGES study can be conducted efficiently as many
components of the proposed study are incorporated
into existing infrastructures and processes at Washington
University: (1) enrolment will be integrated into the
flow of the CPAP; (2) the conduct of the study will
largely be by anaesthesiologists and certified registered
nurse anaesthetists in the course of their routine clinical
work and (3) most of the follow-up data will be obtained
from SATISFY-SOS, an ongoing registry study.
Randomisation can be implemented easily at the point
of patient care, as the anaesthesia protocols do not
require any lead-in time or advanced preparation. The
study will enrol older patients, who are recognised to be
vulnerable and understudied in clinical research. This
targeted population is especially important to under-
stand and would stand to benefit significantly from
reductions in postoperative delirium and related out-
comes. The secondary outcomes of the study include
patient-reported health-related quality of life, which is
extremely relevant to patients. The study is also designed
to detect postoperative falls and their potential preven-
tion. The trial will exploit the extensive SATISFY-SOS
prospective patient registry and our highly evolved peri-
operative electronic medical record. Most of the data
collected for the trial will use existing infrastructure, and
additional data will be entered using the REDCap
resource that integrates well with our other data reposi-
tories. The feasibility of the trial is enhanced by partici-
pation of a multidisciplinary team of investigators that
has now established a track record of collaboration and
completion of major clinical trials. As the intervention is
inexpensive and straightforward, if the results of the
study show compelling effectiveness, it will be logistically
simple to implement and sustain the EEG-guided anaes-
thesia protocol at our institution and disseminate it
nationally in the USA.
The following limitations should be considered. A
single clinical trial should seldom be regarded as defini-
tive. As there is no clear estimate for the prior probabil-
ity that EEG guidance of anaesthesia prevents
postoperative delirium, if the results of this trial do
suggest that EEG guidance of anaesthesia might
decrease delirium at the arbitrary statistical threshold of
p<0.05, it will be necessary to replicate this finding in
future studies. On the other hand, even if the study
finds a non-significant (at the arbitrary threshold of
p>0.05) decrease in delirium in the EEG-guided group,
it is likely that follow-up studies will be warranted to
clarify whether or not there is a clinically meaningful
reduction in delirium with EEG guidance of anaesthesia,
and whether there are specific patient populations that
might especially benefit from this intervention. If EEG
guidance of anaesthesia can prevent postoperative delir-
ium, demonstrating its effectiveness will depend on clini-
cians’ adherence to the protocol. However, the inability
to blind clinicians to the trial allocation group is a
potential source of bias and confounding. We are
attempting to confirm that clinicians do alter anaesthetic
management based on the intervention during the pilot
phase of the study. The inclusion of patients in a clinical
trial focused on the prevention of delirium, and the pro-
vision of practical educational information to patients
and family members could decrease the incidence of
postoperative delirium. Furthermore, if the multicompo-
nent intervention is successful in preventing falls and in
improving quality of life, this could curtail our ability to
detect an impact of the EEG-guided anaesthetic proto-
col on these outcomes. In addition to the pragmatic
structured chart review, there are two clinical assessment
methods that will be used to diagnose delirium: the
CAM-ICU and the CAM. The CAM-ICU is less sensitive
than the CAM, but is the only instrument that has been
validated for patients who are non-verbal (ie, with a
breathing tube or tracheostomy in place). On the basis
of our institutional data, the vast majority of patients
enrolled in the study will be extubated within the first
two postoperative days. Therefore, most patients will
have delirium assessments with the CAM, which is the
more sensitive and specific instrument. We will also test
whether intubation status modifies the result in second-
ary analysis. The study design includes a 30-day and a
1-year follow-up for patient-reported outcomes, and
incomplete follow-up is therefore a potential limitation.
On the basis of our previous B-Unaware and
BAG-RECALL studies,40 41 we are confident that we can
achieve a 30-day follow-up rate of >90%. In our
SATISFY-SOS cohort, the 1-year follow-up has yielded
∼66% response rate. We have performed sensitivity ana-
lysis in our power calculations and have taken into
account this potential attrition in our methods.
Furthermore, we plan to enhance follow-up by using
supplementary phone calls from members of the study
team. As delirium is a fluctuating disorder, there is a risk
that it can be missed by periodic assessments. We are
attempting to mitigate this by assessing patients for delir-
ium during a time of day (afternoon/evening) when
delirium occurs more commonly. Furthermore, we are
incorporating structured chart review, which has been
validated as a complementary approach that increases
the detection of delirium.93 94
Potential benefits, risks and alternatives
Benefits
If the hypotheses motivating this study are correct,
patients who are randomised to receiving EEG guidance
of anaesthesia will have a lower chance of experiencing
postoperative delirium and possibly also its downstream
consequences, including quality of life decrement and
injurious falls. All the patients enrolled in this study will
Wildes TS, et al. BMJ Open 2016;6:e011505. doi:10.1136/bmjopen-2016-011505 13
Open Access
potentially benefit from the safety interventions
intended to decrease the likelihood of postoperative
falls.
Risks
The risks associated with this study are low. There is a
rare risk of breach of confidentiality. The main risk
attributable to the EEG-guided intervention might be
increased risk of intraoperative awareness. This is
unlikely as previous studies that have randomised
patients to EEG guidance have not found an increased
incidence of awareness with EEG-based anaesthetic pro-
tocols.40–42 However, limitations of the BIS in detecting
awareness in the presence of neuromuscular blocking
agents have recently been highlighted.114 Titration of
anaesthesia in the ENGAGES trial is therefore based pri-
marily on the raw EEG waveform and only secondarily
on the processed EEG index. Nonetheless, as a potential
safety concern regarding the EEG-guided intervention
remains that it could increase the incidence of intrao-
perative awareness, this outcome will be tracked post-
operatively with a modified Brice interview115 conducted
within 48 hours of extubation. In addition, questions
regarding intraoperative awareness are also included in
the SATISFY-SOS 1-month survey. A data-safety monitor-
ing committee will review adverse events with the PI
and, in consultation with the institutional review board,
might recommend stoppage of the trial if awareness
events appear to be increased in the intervention group.
As part of the informed consent process for this study,
patients will be informed of the rare risk of awareness.
In the unlikely event that serious side effects occur, they
will be documented and will be reported to the human
research protection office and to the study’s data safety
monitoring board. Participants will not incur any study-
related expenses, nor will they be financially compen-
sated for their participation.
Minimization of risks and confidentiality
Necessary protected health information will only be
shared with members of the research team. To help
protect confidentiality, research charts will be stored in a
locked cabinet inside the locked research office.
Electronic data and demographic information will also be
kept in a password-protected electronic database stored
on the departmental network drive only accessible via
password-protected departmental computers. A member
of the research team will enter this information. Only
code numbers will appear on any data and documents
used for evaluation or statistical analyses. Patients may
choose not to participate in this study, and there will be
no penalty in terms of the care that they receive.
The Division of Biostatistics Informatics Core at
Washington University will be used for data processing
and management. Washington University belongs to a
consortium of institutional partners that work to main-
tain a software toolset and workflow methodology for
electronic collection and management of research and
clinical trial data. REDCap (Research Electronic Data
Capture) data collection projects rely on a thorough
study-specific data dictionary defined in an iterative self-
documenting process by all members of the research
team with planning assistance from the Division of
Biostatistics Informatics Core. The iterative development
and testing process result in a well-planned data collec-
tion strategy for individual studies. REDCap servers are
securely housed in an on-site limited access data centre
managed by the Division of Biostatistics at Washington
University. All web-based information transmission is
encrypted. The data are all stored on a private, firewall-
protected network. All users are given individual user
identifiers and passwords, and their access is restricted
on a role-specific basis. REDCap was developed specific-
ally around HIPAA-Security guidelines and is implemen-
ted and maintained according to Washington University
guidelines. REDCap currently supports >500 academic/
non-profit consortium partners on 6 continents and
38 800 research end users.
Adverse event reporting and safety monitoring
The research team will monitor the study for adverse
events. All serious adverse events (SAEs) will be reported
to the IRB according to IRB stipulations. The monitor-
ing plan for this study is appropriate for the planned
pragmatic trial. We have already conducted three large
clinical studies including ∼28 000 patients, half of whom
received general anaesthesia with EEG guidance. There
were no adverse events attributable to EEG guidance of
anaesthesia in these studies;40–42 it is unlikely that there
will be adverse events attributable to EEG guidance in
the ENGAGES study.
The ENGAGES has an appropriate data and safety
monitoring plan for a low-risk clinical trial. There is a
charter to guide the functions of the DSMB, and the
DSMB will produce reports in accordance with NIH
guidelines. The DSMB will provide independent over-
sight of the ENGAGES Clinical Trial and will review
general conduct of the trial and study data for partici-
pant safety.116 The DSMB is comprised of independent,
multidisciplinary experts who will make recommenda-
tions regarding the continuation, modification or ter-
mination of the trial.117 The members will have the
requisite expertise to examine accumulating data, to
protect the integrity of the clinical experiments to which
the patients have consented to participate and to assure
the regulatory bodies, the public and the NIH that con-
flicts of interest do not compromise either patient safety
or trial integrity.118 The DSMB will convene twice annu-
ally to review safety events. There will be a provision for
early stoppage for safety concerns but not for efficacy or
for futility.116 Trials that stop early for benefit show
implausibly large treatment effects, particularly when
the number of events is small.119 Truncated trials have
been associated with greater effect sizes than trials not
stopped early, independent of the presence of statistical
stopping rules.120 The members of the DSMB shall have
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no direct involvement in the conduct of the ENGAGES
study. Neither shall they have financial, proprietary or
professional conflicts of interest, which may affect the
impartial, independent decision-making responsibilities
of the DSMB.116 117 All DSMB members have signed a
Conflict of Interest Certification to confirm no conflict
exists. There are five people on the DSMB to optimise
performance.121 The DSMB will be advisory rather than
executive on the basis that it is the ENGAGES study
investigators in partnership with the National Institute
on Aging who are ultimately responsible for the conduct
of the trial (see figure 7).121
Premature study termination
Patients in the EEG-guided anaesthetic group will, on
average, receive decreased concentrations of inhaled
anaesthetic agents during their surgeries. Reduction
of anaesthetic administration using simultaneous
EEG-based monitoring of anaesthetic depth has been pre-
viously described without reports of increased intraopera-
tive awareness.27 122 However, it is theoretically plausible
that a significantly higher rate of awareness events could
occur in a cohort that on average receives lower anaes-
thetic concentrations. Therefore, we propose comparing
the incidence of intraoperative awareness reports in the
EEG-guided and usual care groups. We will recommend
to the DSMB that this occurs after 600 patients have been
enrolled. A one-tailed comparison will be used to
compare the incidences of awareness in the groups, and
consideration should be given to terminating the study if
the EEG-guided cohort has a significantly greater inci-
dence of intraoperative awareness compared with the
standard of care group with a p value <0.05. In making
recommendations, the DSMB could take into
consideration the severity of the awareness experiences,
including reports of pain, paralysis and distress.123 Apart
from intraoperative awareness, it is not currently hypothe-
sised that decreased anaesthetic administration is asso-
ciated with clinically relevant adverse outcomes (eg,
death, myocardial infarction, stroke). It is possible that
decreases in anaesthetic administration might be asso-
ciated with intraoperative patient movement, or with
increased intraoperative blood pressure and heart rate.
However, these are surrogate measures with unclear clin-
ical relevance, which should not therefore impact a deci-
sion to terminate the study early.
We recommend to the DSMB not performing an
interim analysis of delirium rates for any consideration
of termination. Currently, available data support the pos-
sibility that an EEG-guided anaesthetic management to
reduce anaesthetic administration might decrease the
incidence of postoperative delirium or have no effect on
this outcome.26–29 Conversely, the possible finding of a
higher incidence of delirium in the EEG-guided cohort
would conflict with current evidence. When interpreted
in the context of existing evidence, the finding of signifi-
cantly disparate incidences of postoperative delirium in
a partially completed ENGAGES trial would not provide
a sufficient evidence base to change the standard of
practice for anaesthetic guidance of these patients.
Indemnity
Washington University School of Medicine is responsible
for any non-negligent damage incurred as a result of
participating in the ENGAGES trial. The indemnity is
renewed on an annual basis. Washington University
School of Medicine assures that it will continue renewal
of the indemnity for the duration of the trial.
Figure 7 ENGAGES trial organization.
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Ethics and dissemination
The trial steering committee will be responsible for all
major decisions regarding changes to the protocol. The
committee will communicate these changes to the IRB
and appropriate parties. The final trial data set is the
property of the investigative team and shall not be shared
without permission from the principal investigator. Data
will be shared with the National Institute on Aging.
Dissemination plans include presentations at local,
national and international scientific conferences. Every
effort will be made to publish results of the ENGAGES
trial in a peer-reviewed journal. Dissemination of results
to study participants and their family members will be
available upon request. Updates and results of the study
will be available to the public at clinicaltrials.gov.
ADDENDUM
Prespecified substudies
A. Duration and severity of delirium: In addition to the
incidence of delirium (the primary outcome of the
ENGAGES study), other outcomes of interest will be
the duration of delirium and the severity of delirium,
both of which have been shown to have prognostic
importance.124–128 The severity of delirium will be
scored using the CAM-Severity (CAM-S) metric,
which has specifically been shown to be strongly
associated with clinically relevant outcomes.128
Delirium will also be assessed postoperatively on the
day of surgery, when patients are sufficiently awake
(RASS >−4).
B. Agreement among the FAM-CAM, researchers’
delirium assessments and patient perceptions: The
ENGAGES study is a patient-centred study. As such,
the active involvement of patients and their families
is an important component. The family confusion
assessment method (FAM-CAM) instrument has pre-
viously been shown to have good agreement with the
CAM and with DSM-IV diagnostic criteria in patients
with cognitive impairment and in hospitalised
patients.103 104 The utility of the FAM-CAM has not
been established in postoperative patients; however, it
has been successfully implemented in the post-
operative setting in the ongoing PODCAST clinical
trial.129 Patients will also complete a delirium self-
assessment questionnaire (see online supplementary
appendix). The FAM-CAM assessments and the
patients’ self-assessments will be compared with the
researchers’ delirium assessments.
C. Duration or recurrence of delirium after hospital dis-
charge as measured by the FAM-CAM and patient
perceptions: Little is currently known about either
duration of delirium or recurrence of delirium after
hospital discharge in postoperative patients. The
FAM-CAM and patient self-reports will be used to
assess these outcomes.
D. Clinically relevant outcomes associated with delirium:
Delirium incidence, duration and severity have all
been shown to be associated with other (down-
stream) clinically relevant outcomes, including mor-
tality, length of ICU stay, length of hospital stay, falls,
cognitive decline and functional decline. In the
ENGAGES study, these associations will be explored.
The data on downstream outcomes will be obtained
from hospital records or from patient-reported
outcome measures that are collected as part of the
ongoing SATISFY-SOS study.
E. Comparison of patient-reported and observational pain
scores: It is likely that patients with delirium are less
able to convey verbally the extent to which they are in
pain.130 Given that postoperative delirium is common
and may relate to uncontrolled pain, this has import-
ant implications for the assessment and treatment of
postoperative pain. We plan to compare patient-
reported and behavioral pain assessments in non-
delirious and delirious patients130 (see online supple-
mentary appendices for pain assessment instruments)
F. Postoperative actigraphy and EEG: Postoperative distur-
bances in sleep and EEG abnormalities have previously
been associated with postoperative delirium.131–134
EEG data will be collected from some patients at
around the time of delirium assessments. Patients
might also wear actigraphy watches to help distinguish
episodes of sleep from wakefulness in the postoperative
period.135
G. Relationship between clinical CAM-ICU and rigorous
delirium assessments: Routine clinical (ie, conducted
by ICU nursing staff) delirium assessments in the
intensive care units (conducted with the CAM-ICU)
will be collected when these are available.
Comparison will be made between these routine clin-
ical assessments and the assessments made by the
research team.
H. Association between delirium and patient outcomes:
The ENGAGES study will evaluate the association
between postoperative delirium and patient-reported
outcome metrics, including quality of life and falls,
up to 1 year postoperatively.
I. Postoperative outcomes hypothesised to be associated
with anaesthetic depth: It is likely that patients rando-
mised to the EEG-guided protocol will be exposed to
lower concentrations of anaesthetic agents and on
average will not be as deeply anaesthetised. There is an
ongoing randomised, clinical trial investigating the
effects of depth of anaesthesia on a range of out-
comes,101 102 including death, myocardial infarction,
cardiac arrest, pulmonary embolus, stroke, surgical site
infection, ICU length of stay, hospital length of stay,
intraoperative awareness, persistent pain and cancer
recurrence. Many of these outcomes are tracked with
the SATISFY-SOS study and will therefore be reported
for patients enrolled in the ENGAGES study.
J. Delirium prediction models: It is important to
improve our understanding of factors that are asso-
ciated with an increased incidence of postoperative
delirium or perhaps may even mediate an elevated
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risk for postoperative delirium. Previous studies have
explored risk factors, usually using logistic regression
models.29 136–147 In a previous study, we used a
Bayesian exploratory approach with a stochastic
search variable selection method.29 The ENGAGES
study will rigorously assess a large number of surgical
patients for postoperative delirium, and it will there-
fore lend itself to further exploration, refinement of
risk models and hypothesis generation. On the basis
of the results from previous studies, we will include
specific variables in our analyses. Patient age, demo-
graphic, lifestyle and comorbidity information will be
assessed at baseline through a standardised interview
in the CPAP clinic. Data on previously described risk
factors for postoperative delirium will be acquired
including history of postoperative delirium, modified
Charlson Comorbidity Index, American Society of
Anesthesiologists’ Physical Status, functional status,
level of education, olfaction, baseline cognition,
depression (using the PHQ-9 questionnaire), indices
of frailty, obstructive sleep apnoea, baseline haemato-
crit, baseline sodium and creatinine, preoperative
psychoactive medications (eg, opioids, benzodiaze-
pines, sedatives, clonidine), alcohol use, dosages of
perioperative medications (eg, hypnotic anaesthetics,
opioids, benzodiazepines, dexmedetomidine), intrao-
perative hemodynamic parameters, other physio-
logical parameters, processed EEG indices (eg, BIS,
burst suppression), vasoactive medications, peri-
operative blood transfusions, postoperative mechan-
ical ventilation, postoperative pain (using Visual
Analogue Scale and Behavioural Pain Scale), post-
operative sleep deprivation, postoperative medical
complications, postoperative shock, postoperative
anaemia (haematocrit <30%), postoperative hypoal-
buminemia (albumin <3 g/dL), postoperative tem-
perature and postoperative sodium
concentration.29 79 136–147
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